Physician profile
Meredith Gunder
NPI 1093244741
$1,923.63
in general payments reported to CMS, 2019-2025
14 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.84 · 2022: $255 · 2023: $54.77 · 2024: $1,353 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $582.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,144.44 | 2024-2025 | |
| Atricure, INC. | $255.48 | 2022 | |
| Dilon Technologies, INC. | $145.21 | 2024 | Hemoblast Bellows |
| Ethicon US, LLC | $124.80 | 2021-2025 | Stratafix |
| Medtronic, INC. | $41.48 | 2023 | Signia, Emprint |
| Astrazeneca Pharmaceuticals LP | $36.56 | 2024 | Enhertu |
| Merck Sharp & Dohme LLC | $36.32 | 2024 | Keytruda, Lynparza |
| Alcresta Therapeutics, INC. | $24.68 | 2024 | Relizorb |
| Pfizer INC. | $24.20 | 2024 | |
| Incyte Corporation | $21.01 | 2024 | Monjuvi, Pemazyre, Jakafi |
| Lilly USA, LLC | $20.77 | 2024 | Jaypirca, Verzenio, Retevmo |
| Csl Behring | $20.36 | 2025 | Kcentra |
| Eisai INC. | $15.03 | 2024 | |
| Acera Surgical, INC. | $13.29 | 2023 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Gunder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.